Infectious Disease Flashcards
Most commonly identified viruses
causing sporadic cases of acute encephalitis in immunocompetent adults
Herpesvirus, VZV, EBV
CSF sample to be taken for encephalitis
20mL, 5-10mL frozen for study
CSF profile of viral encephalitis
A. Lymphocytic pleocytosis,
*>5cells/mcL in immunocompetent indls
* Severely Immunocompromised: May fail to mount a CSF inflammatory response
* > 1000/mcL: Non-viral infection; arbovirus, mumps, LCMV
B. Mildly elevated protein conc
C. Normal gluc conc
- Atypical Lymphocytes: CMV, HSV, enteroviruses
- WNV encephalitis: Plasmacytoid or Mollaret-like large mononuclear cells
- Persistent CSF neutrophilia: Bacterial infection, leptospirosis, amebic infection, and noninfectious processes - acute hemorrhagic leukoencephalitis
Primary diagnostic test for CNS infections caused by CMV, EBV, HHV-6, and enteroviruses
CSF PCR
- HSV CSF PCR (sensitivity 96%; specificity ~99%)
CSF Ab testing of value to which patients
> 1 week in duration and CSF PCR negative for HSV
Diagnostic of WNV encephaltiis
WNV IgM Ab
- IgM antibodies do not cross the blood-brain barrier, and their presence in CSF is therefore indicative of intrathecal synthesis.
- Increases 10% per day after illness onset 70-80% by end of first week
Imaging findings of HSV encephalitis
Focal findings: consider HSV encephalitis
1. T2 weighted FLAIR or DW MRI: increased signal intensity in the frontotemporal, cingulate or insular regions of the brain
2. CT: focal areas of low absorption, mass effect, contrast enhancement
3. EEG: Periodic focal temporal lobe spikes on background of slow or low-amplitude (flattened act)
* periodic, stereotyped, sharp-and-slow complexes, one or both temporal lobes and repeating at regular intervals of 2-3 s
Imaging findings of WNV encephalitis
FLAIR: deep brain- thalamus, basal ganglia, brainstem abnormalities
EEG: Generalized slowing, anteriorly prominent
Imaging findings of VZV
- multifocal areas of hemorrhagic and ischemic infarction, reflecting the tendency of this virus to produce a CNS vasculopathy rather than a true encephalitis
Imaging findings of CMV
Enlarged ventricles with areas of increased T2 on MRI- ventricles and subependymal enhancement on T1 weighted
Indication of Brain Biopsy for encephalitis (4)
- CSF PCR studies fail to lead to a specific diagnosis
- Have focal abnormalities on MRI
- No serologic evidence of autoimmune disease
- Show progressive clinical deterioration despite treatment with acyclovir and supportive therapy
Diagnosis of rabies virus antigen
Virus Ag in brain tissue or in neural innervation of hair follicles at the nape or neck
Treatment of HSV, EVB, VZV encephalitis
Acyclovir 10mg/kg IV every 8h (max 30mg/kg/d) x 21 days - started empirically if suspecting viral encephalitis, especially focal features
Treatment of HSV encephalitis
Ganciclovir
* Induction: 5mg/kg every 12h IV at constant rate over 1h (severe neurologic illness)
* Maintenance: 5mg/kg OD indefinitely
* Continued until: decline in CSF pleocytosis and reduced CSF CMV DNA copy number on quantitative PCR testing
Foscarnet
I: 60mg/kg every 8h constant infusion over 1h x 14-21 days
* Extend if failed to show a decline in CSF pleocytosis and reduction in CSF CMV DNA
M: 60-120mg/kg/d
Cidofovir: Nucleotide analogue for CMV retinitis
* 5mg/kg IV once weekly x 2 weeks then biweekly for 2 or more additional doses
* Prehydrated with normal saline 1L over 1-2h then probenecid
* Nephrotoxicity
MRI findings of progressive multifocal leukoencephalopathy
- multifocal asymmetric, coalescing WM lesions located periventricularly in the centrum semiovale, in the parietal-occipital region and in cerebellum
- Increased signal on T2 and FLAIR images
- Decreased on T1-weighted images
- HIV-PML: Non-enhancing
- Immunomodulatory: Peripheral ring enhancement
Management of progressive multifocal leukoencephalopathy
- 5HT2a receptor Mirtazapine: inhibit binding of JCV to its receptor on oligodendrocytes
- Interferon alpha
- Cytarabine: breakdown of BBB allows sufficient CSF penetration
- Severe CNS inflammatory syndrome (IRIS): clinical worsening, CSF pleocytosis, appearance of new enhancing MRI lesions
- Tx: IV glucocorticoids
- Natalizumab: STOPPED
- Tx: Plasma exchange or immunoadsorption
Initial presentation of Subacute Sclerosing Panencephalitis
Poor school performance, mood and personality changes
Most common organism for Community-acquired bacterial meningitis
Streptococcus pneumoniae (~50%)
Neisseria meningitidis (~25%)
Group B strep (~15%)
L. monocytogenes (~10%)
Most important predisposing condition for s. pneumoniae meningitis
pneumococcal pneumonia
- RF: sinusitis or otitis media, alcoholism, DM, splenectomy, hypogammaglobulinemia, complement deficiency, head trauma with basilar skull fracture, CSF rhinorrhea
Bacteria that complicates neurosurgical procedures and head trauma associated CSF rhinorrhea or otorrhea
Gram negative bacilli
Bacteria following invasive neurosurgical procedures such as shunting, ommaya reservoirs
S. aureus and CONS
Presentation of patient’s with raised ICP
- Deteriorating or reduced level of consciousness, papilledema, dilated poorly reactive pupils, 6th nerve palsies, decerebrate posturing, cushing reflex
- Cushing reflex: bradycardia, hypertension, irregular respirations
Most disastrous complication of increased ICP
Cerebral herniation
Indications to proceed with lumbar puncture without prior neuroimaging (4)
- Immunocompetent patient
- no known history of recent head trauma
- a normal level of consciousness
- no evidence of papilledema or focal neurologic deficits
CLASSIC CSF Abnormalities in BACTERIAL MENINGITIS
- PMN leukocytosis (>100 cells/uL in 90%)
- Decreased CSF Glucose
- <40 mg/dL
- CSF/serum glucose ratio of <0.4 in ~60%
- Increase protein concentration (>45 mg/dL in 90%)
- Increased opening pressure (>180 mmH2O in 90%)
* CSF Glucose concentrations <40mg/dl (Abnormal)
* CSF glucose concentration of zero= bacterial meningitis
* CSF/serum glucose <0.6 = CSF glucose con’c is LOW
* CSF/serum glucose <0.4 = HIGHLY suggestive of BAC MEN (may be seen in fungal, TB and carcinomatous meningitis)
Empirical therapy of Community-Acquired Suspected bacterial meningitis in children and adults
Dexamethasone + Third- or Fourth-Gen cephalosporins (Ceftriaxone/Cefotaxime/Cefepime) and Vancomycin plus (Acyclocivr or Doxycycline)
Treatment for susceptible S. pneumonia, group B strep, H. influenza and adequate coverage for N. meningitides
Ceftriaxone or Cefotaxime
When to add Ampicillin to empirical regimen in Bac Men?
For coverage of L. monocytogenes, <3 months of age, those > 55, those with imapired cell mediated immunity
- AMPICILLIN for at least 3 weeks
When to add Metronidazole to empirical regimen in Bac Men?
Gram-negative anaerobes in patients with otitis, sinusitis,
or mastoiditis
Empiric regimen for HA meningitis, particulalry during neurosurgical procedures
- Cover for Staph, gram neg including P. aeruginosa
- Vancomycin and Ceftazidime OR Meropenem
- MEROPENEM SHOULD NOT BE USED AS MONOTHERAPY!!!
Treatment of Meningococcal Meningitis?
- PENICILLIN G - antibiotic of choice for Penicillin-seinsitive
- CEFOTAXIME / CEFTRIAXONE - if with Penicillin resistance
- Uncomplicated: 7 day course
Meningococcal hemoprophylaxis for index case and close all contacts (3)
- RIFAMPIN 600 mg every 12 h for 2 days in adults
- Alternative: Azithromycin 500 mg x1 dose
- Alternative: Ceftriaxone 250 mg IM x1dose
- Close contacts are defined as individuals who have had contact with oropharyngeal secretions, either through kissing or by sharing toys, beverages, or cigarettes.
When do you repeat LP in patients with S. pneumoniae meningitis?
Repeat LP performed 24-36H after initiation of antimicrobial therapy to document sterilization of CSF
Failure to sterilize the CSF after 24–36 h of antibiotic therapy should be considered presumptive evidence of antibiotic resistance.
Penicillin- and cephalosporin-resistant strains of S. pneumoniae who do not respond to intravenous vancomycin alone may benefit from the addition of intraventricular vancomycin.
Regimen to be added with Listeria Menigitides for critically ill patient
Gentamicin (2 mg/kg loading dose, then 7.5 mg/kg per day
given every 8 h and adjusted for serum levels and renal function).
Alternative for patients with L. monocytogenes menigitis with penicillin-allergy?
- COTRIMOXAZOLE - alternative in penicillin-allergic patients
- TMP 10-20mg/kg/day
- SMX 50-100mg/kg/d every 6 hours